2 Numbers That Should Make Novavax Shareholders Smile

Novavax (NASDAQ: NVAX) missed Wall Street's revenue estimate in the fourth quarter of 2021. And it didn't matter. As proof, the vaccine maker's shares rose on Tuesday after Novavax's Q4 update following the market close on Monday.

But some things in the company's update really do matter. Here are two numbers that should especially make Novavax shareholders smile.

Image source: Getty Images.

Continue reading

Source Fool.com